Knight Therapeutics | GUD - Market Capitalization

Stock Price
6.40
Daily Change
0.02 0.31%
Monthly
9.59%
Yearly
15.94%
Q1 Forecast
6.28

Knight Therapeutics reported CAD644.46M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 322M 180M Jun/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
Aurora Cannabis CAD 470.14M 146.16M Sep/2025
Avita Medical AUD 140.79M 194.8M Jun/2025
Canopy Growth CAD 136.67M 644.68M Feb/2026
Cronos Group USD 1.06B 319.22M Sep/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Ionis Pharmaceuticals USD 12.46B 2.03B Feb/2026
IQVIA Holdings USD 32.84B 5.54B Feb/2026
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Moderna USD 16.5B 6.41B Feb/2026
Omeros USD 184M 158M Sep/2023
Organigram Holdings CAD 191.77M 187.03M Feb/2026
Organon & Co USD 1.89B 29.17M Feb/2026
Revvity USD 12.58B 1.61B Feb/2026
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 11.54B 1.06B Sep/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026